The Council advocates the development of sustainable healthcare systems around the world. CHP engages with Governments & stakeholders to evolve innovative approaches that optimise the value chain & ecosystem involved in treating human disease & improving healthcare standards. As a significant and credible stakeholder in alleviating the burden of disease, the CHP brings to bear the collective wisdom of policy makers & industry (Pharmaceutical companies, Providers of Diagnostics, Medical Device Manufacturers, Hospitals & adjunct services) on health issues that make a difference to society. The CHP has been set-up to create a global environment for sustainable development & growth of the Healthcare & Pharma industries through consistent steering of issues and advisory actions. CHP’s prime focus will be on Africa, Brazil, China, France, Germany, India, Japan, UK & USA. Its important areas of work will be in ease-of-doing business; increasing competitiveness; broadening access to safe, efficacious and affordable healthcare services & medicines. CHP envisages building of a base for Innovation, Generics, Contract Manufacturing and value added healthcare services, while promoting the ‘Make in India’ advantage. CHP will have a global foot print & members from its focus geographies to advocate the merits of a strong, vibrant Global Healthcare & Pharmaceutical Industry. The Council’s aim will be to provide thought leadership on matters critical to healthcare. The Council’s role will include but not be limited to stimulating the generation, translation & dissemination of valuable knowledge, technical support, & catalyzing necessary change while building sustainable institutional capacity. The main scope will be to address Industry issues with Government, forge partnerships, strike synergies & collaborate with like-minded Institutions. It will organize seminars on relevant, contemporary issues & engage with the brightest minds to address such domains comprehensively.